Carl Icahn is setting up a fight for control at Illumina (ILMN) after what the activist investor called an “ill-advised and frankly inexplicable” acquisition of Grail. In response, ILMN st...
Tag: ILMN
WSJ: Carl Icahn says Grail deal cost Illumina shareholders $50 billion
Shares of Illumina Inc. ILMN, +14.70% were up about 8% in premarket trading on Monday after the Wall Street Journal reported Sunday that Carl Icahn is planning a proxy fight. The billionaire activist ...
ILMN, FRC, SGEN & More
Offices of Illumina, in San Diego, California. Mike Blake | Reuters Check out the companies making headlines before the bell. First Republic — Shares of First Republic cratered more than 64% before th...
Why a Long-Term Investor Is Sticking With Tesla and Cloud Shares
Everything about the investment approach at Baillie Gifford screams patience. Founded more than 110 years ago, the Scottish portfolio management firm, which oversees $250 billion, is a believer in the...
Rivian, Illumina, Toast, and More Stock Market Movers Friday
Text size Rivian, the maker of electric trucks, maintained its production estimates for the full year. Courtesy Rivian Stock futures rose Friday amid more signs that inflation in the U.S. has been coo...
Disney, Coinbase, BioNTech, Rivian, and Other Stocks to Watch This Week
Text size Second-quarter earnings season continues this week, while a pair of July inflation figures and consumer sentiment surveys will be the highlights on the economic-data calendar. On Monday, Tys...
Disney, Coinbase, BioNTech, Rivian, and Other Stocks for Investors to Watch This Week
Text size Second-quarter earnings season continues this week, while a pair of July inflation figures and consumer sentiment surveys will be the highlights on the economic-data calendar. On Monday, Tys...
Illumina Stock Plunges Despite Strong Results, Gene-Sequencing Sales
Text size Illumina turned in stronger financial results than expected. Dreamstime The gene-sequencing supplier Illumina delivered on its March quarter financial forecasts, as global demand for genetic...
James Anderson of Baillie Gifford on Illumina, Moderna, and Other Companies That Matter
James Anderson, a partner at Scottish money manager Baillie Gifford, has personified growth-stock investing during his 39 years with the firm. He was an early backer of Amazon.com, Tesla, and other “e...